31 Mar 2023
Assets6.22
Total Income13.90
EBITDA0.57
Profit After Tax0.19
NET Worth0.97
Reserves and Surplus0.67
Total Borrowing2.21
Open 23rd Sep 2025 · Close 25th Sep 2025 · Listing 30th Sep 2025
The shares listed at ₹80.80, a 15.43% move from the issue price. Aptus Pharma is a SME IPO with an issue size of ₹13.02 crore, proposed for listing on BSE SME. The offer opens on 23rd Sep 2025 and closes on 25th Sep 2025. The issue structure includes a fresh issue of ₹12.36 crore. The current listing schedule points to 30th Sep 2025.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 4000 | ₹280,000 |
| Object | Amount |
|---|---|
| Capital Expenditure for Office Premises with furniture and Industrial Racks | ₹1.63 Cr |
| Working Capital | ₹8.00 Cr |
| General Corporate Purposes | ₹1.91 Cr |
| Issue Expenses | ₹1.48 Cr |
| Total | ₹13.02 Cr |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 44.50% |
| ROCE | 45.66% |
| Debt / Equity | 1.49% |
| RoNW | 44.50% |
| PAT Margin | 12.62% |
| EBITDA Margin | 19.31% |
| Expense | Amount |
|---|---|
| Capital Expenditure for Office Premises with furniture and Industrial Racks | ₹1.63 Cr |
| Working Capital | ₹8.00 Cr |
| General Corporate Purposes | ₹1.91 Cr |
| Issue Expenses | ₹1.48 Cr |
| Total | ₹13.02 Cr |